Board of Directors
Officers
Advisory Board
Officers
- Daniel N. Chicoine, CA - Chairman & Co-Chief Executive
Officer
Since 1982, Mr. Chicoine has held various positions at the Magna group of companies,
including President and CEO of Atoma International Inc. While Mr. Chicoine was the
CEO of Atoma, he succeeded in growing its business from $300 million per annum to $1
billion and effected a major restructuring. In May 1994, Mr. Chicoine formed Triam
Automotive Inc., an automobile parts supplier, with other former executives of Magna
and, in July 1994, was instrumental in assisting the company in completing an initial
public offering. While at Triam, he acted as Vice Chairman in charge of sales. After
leaving Triam in 1996, Mr. Chicoine, along with two other former executives of Magna,
formed Nighthawk Investments, a small investment company. Mr. Chicoine has also served
as the President of PowerCart Systems Inc., a Markham-based private company that designs
and manufactures battery-equipped workstations that power devices with wireless communication
capability. Mr. Chicoine is a chartered accountant by profession.
- Dr. Henrich R.K. Guntermann, MD, MSc - President, Europe &
Immunology Group
President and CEO, Nuvo Research Inc. Dr. Guntermann has more than 15 years of experience in the
life sciences sector (including business development, restructuring and corporate financing).
With a group of distinguished life sciences entrepreneurs, he founded BioAlliance AG, a
German-based life sciences private equity and consulting firm. BioAlliance was formed to
capitalize on the early stage development of the life sciences industry in the European
Union, by developing life sciences companies and leveraging their technologies and products
worldwide. Through its established international network, it brings together life sciences
companies in the United States, Asia and Europe to foster growth through alliances. In addition,
BioAlliance consults for international life sciences companies (pharmaceutical, medical devices,
diagnostics and agro-biotech) in different stages of development, including large scale players
in the life sciences sector and public institutions, such as city and state governments, the
European Commission and the United Nations Industry Development Organization (UNIDO). Dr. Guntermann
received his medical doctorate at the Philipps-University in Marburg, Germany. He also received a
Masters of Science in Biology, with specialization in pharmacology/toxicology and human genetics.
- John C. London, LLB, LLM - President &
Co-Chief Executive Officer
Mr. London is a graduate of the University of Western Ontario law school and holds a Masters of Law Degree from University College London. He was a partner with the Toronto law firm of Strathy, Archibald and Seagram (now Gowlings) where he practiced from 1981 to 1988. In 1988, Mr. London joined Magna International Inc., one of the world's largest automotive parts suppliers. From 1988 to 1993, he was Executive Vice-President and General Counsel at Atoma International Inc., Magna's interior systems group. In 1994, Mr. London co-founded Triam Automotive Inc., a private auto parts supplier, where he served as Executive Vice-President. Mr. London and his partners took Triam public and sold it to Magna in 1998. In 1997 Mr. London co-founded Nighthawk Investments, a private investment firm. From 2002 to 2005, Mr. London was President and Chief Executive Officer of Powercart Systems Inc. a private company that designs and manufactures battery equipped workstations that power devices with wireless communication capability.
- Jim Moulds, CA, MAcc, BA - Executive Vice President & Chief
Financial Officer
Mr. Moulds has over 15 years of public company experience and oversees all of Nuvo's financial operations and is responsible for information technology and manufacturing operations. Prior to joining Nuvo in 2006, Mr. Moulds was the Senior Vice President, Finance for Tesma International Inc. ("Tesma"), a company listed on the TSX and NASDAQ, until it completed a "going private" transaction with Magna International Inc. in 2005 and earlier
he had served in various capacities including Corporate Controller and Vice President, Finance and Treasurer. Mr. Moulds played an integral role on the executive management team that took Tesma public in 1995, growing its sales from $344 million to $1.7 billion in 2005 with operations on 4 continents. During his tenure, he performed a key role in several public equity issues, debt financings, acquisitions and strategic planning. Prior to joining Tesma, Mr. Moulds worked in various financial capacities for Magna International Inc. and early in his career for Ernst & Young LLP performing audit, tax and accounting work for its clients. Mr. Moulds holds a Master of Accounting from the University of Waterloo, where he also earned his undergraduate degree.
|
|
